This design (MitoGuard) is a fragment of MOTS-c (88%) — and MOTS-c is the characterised, HPLC-verified compound in that family.
Designed sequences are novel hypotheses that still have to be synthesised. MOTS-c is real material you can study now — ≥99% HPLC-verified, batch Certificate of Analysis included, dispatched from the UK in 24h.
Velox Design Lab outputs are computational sequence predictions for in vitro research use only. They are hypotheses, not validated compounds, and are not a medicinal product, not medical advice, and not for human or veterinary use. See our Research Use Policy.